GlassScriptPhysician profile
Samuel G Eisenstein
NPI 1194983932
$33,782.80
in general payments reported to CMS, 2019-2025
16 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,324 · 2020: $10K · 2021: $6,157 · 2022: $5,415 · 2023: $2,363 · 2024: $137 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,999 · Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,998.75 |
| Food and Beverage | $842.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $25,406.93 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $4,138.81 | 2020-2023 | |
| Medtronic, INC. | $1,609.76 | 2022-2025 | Interstim, Eea, Signia |
| Covidien LP | $875.00 | 2019 | |
| Asensus Surgical, INC. | $600.00 | 2022 | |
| Intuitive Surgical, INC. | $496.65 | 2019-2025 | Da Vinci Surgical System |
| Medtronic USA, INC. | $280.04 | 2019-2020 | |
| Teleflex LLC | $85.51 | 2024 | Solesta |
| Ethicon US, LLC | $80.92 | 2023-2024 | Echelon; Endopath, Vistaseal, Surgiflo Hemostatic Matrix |
| Aroa Biosurgery Incorporated | $63.80 | 2025 | |
| Axonics, INC. | $44.63 | 2022-2023 | Axonics |
| Davol INC. | $41.04 | 2025 | Arista, Phasix Mesh |
| Acadia Pharmaceuticals INC | $23.05 | 2023 | Nuplazid |
| Vioptix INC | $20.66 | 2023 | |
| Convatec INC. | $16.00 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Eisenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.